Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The liver and methotrexate].
Laharie D, Terrebonne E, Vergniol J, Chanteloup E, Chabrun E, Couzigou P, de Lédinghen V. Laharie D, et al. Among authors: chanteloup e. Gastroenterol Clin Biol. 2008 Feb;32(2):134-42. doi: 10.1016/j.gcb.2007.11.002. Gastroenterol Clin Biol. 2008. PMID: 18494155 Free article. Review. French.
Changes of non-invasive markers and FibroScan values during HCV treatment.
Vergniol J, Foucher J, Castéra L, Bernard PH, Tournan R, Terrebonne E, Chanteloup E, Merrouche W, Couzigou P, de Lédinghen V. Vergniol J, et al. Among authors: chanteloup e. J Viral Hepat. 2009 Feb;16(2):132-40. doi: 10.1111/j.1365-2893.2008.01055.x. Epub 2008 Oct 17. J Viral Hepat. 2009. PMID: 19175875
Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A, Bommelaer G, Dib N, Bigard MA, Viennot S, Hébuterne X, Gornet JM, Marteau P, Bouhnik Y, Abitbol V, Nahon S; GETAID. Abitbol Y, et al. Among authors: chanteloup e. J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11. J Crohns Colitis. 2016. PMID: 27402916
Vedolizumab for perianal Crohn's disease: a multicentre cohort study in 151 patients.
Chapuis-Biron C, Bourrier A, Nachury M, Nancey S, Bouhnik Y, Serrero M, Armengol-Debeir L, Buisson A, Tran-Minh ML, Zallot C, Fumery M, Bouguen G, Abitbol V, Viennot S, Chanteloup E, Rajca S, Dib N, Parmentier AL, Peyrin-Biroulet L, Vuitton L; GETAID BioLAP Study Group. Chapuis-Biron C, et al. Among authors: chanteloup e. Aliment Pharmacol Ther. 2020 Apr;51(7):719-727. doi: 10.1111/apt.15665. Epub 2020 Feb 20. Aliment Pharmacol Ther. 2020. PMID: 32080886
Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID.
Chapuis-Biron C, Kirchgesner J, Pariente B, Bouhnik Y, Amiot A, Viennot S, Serrero M, Fumery M, Allez M, Siproudhis L, Buisson A, Pineton de Chambrun G, Abitbol V, Nancey S, Caillo L, Plastaras L, Savoye G, Chanteloup E, Simon M, Dib N, Rajca S, Amil M, Parmentier AL, Peyrin-Biroulet L, Vuitton L; GETAID BioLAP Study Group. Chapuis-Biron C, et al. Among authors: chanteloup e. Am J Gastroenterol. 2020 Nov;115(11):1812-1820. doi: 10.14309/ajg.0000000000000810. Am J Gastroenterol. 2020. PMID: 33156100
16 results